Was there an official announcement about a patent litigation settlement involving Rigel’s TAVALISSE (fostamatinib)?
Rigel Pharmaceuticals (and related parties) have at times disclosed legal and patent matters in public filings, but the specific “settlement date” and whether an “official announcement” exists for a particular TAVALISSE-related patent litigation event depends on the exact case (docket/case name) and the date Rigel released the disclosure.
To answer your question precisely, you typically need one of these identifiers:
- the exact patent or lawsuit name (or docket number),
- the announcement date you’re looking for (month/year),
- whether the settlement involves a Paragraph IV/ANDA biosimilar or generic-type challenge (often the context for TAVALISSE patent disputes),
- or a link to the article/post you saw.
Where would Rigel publish the “settlement date” if it did?
Rigel commonly reports material legal developments through:
- SEC filings (especially 10-K, 10-Q, and 8-K), where settlement timing and outcomes are described if they are material; [1]
- press releases, if the company treats the resolution as market-relevant; [2]
If you can share the lawsuit/patent identifier (or paste the text of what you found), I can pinpoint the exact settlement date and the corresponding official disclosure.
Why the settlement date can differ from the “trial/filing” date
Even when a settlement is reached, public “official announcement” timing can vary:
- Settlement negotiations may conclude on one date, but the company may disclose only after paperwork is executed, a consent order is filed, or an SEC filing is made.
- Some settlements are reported only as “ongoing” until they meet a materiality threshold.
What I need from you to give the exact settlement date and link
Please provide one of the following so I can locate the correct official announcement and date:
1) the patent number (or “U.S. Patent No.”) involved, or
2) the case caption (e.g., “Rigel v. [company]” or the defendant name), or
3) the docket number, or
4) a URL to the announcement/article you’re referencing, or
5) the approximate month/year you think the settlement was announced.
If you’re checking: “settlement vs. exclusivity vs. patent expiry”
People sometimes conflate three different timelines:
- patent expiration (end of the granted patent term),
- any regulatory exclusivity (separate from patents),
- and a litigation settlement (which may occur well before or after key dates).
If you tell me which timeline you mean (settlement announcement date versus patent expiry), I’ll align the answer accordingly.
---
Sources
[1] https://www.sec.gov/edgar/searchedgar/companysearch.html
[2] https://investors.rigel.com/news-releases/